Thromboprophylaxis Strategy in Cancer Outpatients

Reducing the Risk of Thromboembolism in CancerПодробнее

Preventing VTE in Patients With CancerПодробнее

Quick Tips for VTE Prophylaxis for Ambulatory Medical Oncology PatientsПодробнее

Dalteparin Thromboprophylaxis in Cancer PatientsПодробнее

Primary prophylaxis of venous thromboembolism (VTE) in ambulatory cancer patients.Подробнее

Updated ASCO guidelines for VTE in cancerПодробнее

VTE Prophylaxis in Patients with Cancer with Dr. Jean ConnorsПодробнее

VTE Prevention in Cancer Patients - Alok A. Khorana, MDПодробнее

Prediction and Prevention of Cancer-Associated Thromboembolism (CAT)Подробнее

Following Thromboprophylaxis Guidelines in Cancer Patients-the Real WorldПодробнее

DOAC VTE Prophylaxis for Patients with CancerПодробнее

Screen and use thromboprophylaxis in cancer patients at high-risk for venous thromboembolismПодробнее

Webinar: VTE Burden of Disease and Prophylactic ConsiderationsПодробнее

Duration of thromboprophylaxis in inpatients with cancerПодробнее

Updates in Cancer Associated ThrombosisПодробнее

Alok A. Khorana: Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer PatientsПодробнее

22. Anticoagulation in high bleeding risk cancer patients - Dr Nolukholo NceteПодробнее

Thrombosis Management in Oncology PatientsПодробнее

Venous Thromboembolism: Assessing the Risk in Hospital...and Beyond [MUST WATCH]Подробнее